LY2275796 Completed Phase 1 Trials for Advanced Cancers Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00903708LY2275796 in Advanced Cancer